Gilead Sciences reported $1.39B in Cost of Sales for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US $ 4499M 307M
Acorda Therapeutics ACOR:US $ 11.32M 0.64M
Alexion Pharmaceuticals ALXN:US $ 125.4M 26.8M
ALKERMES ALKS:US 53.12M 12.1M
Alnylam Pharmaceuticals ALNY:US $ 30.26M 7.23M
Amgen AMGN:US $ 1637M 147M
Biogen BIIB:US $ 459.7M 18.4M
Biomarin Pharmaceutical BMRN:US $ 127.06M 6.9M
Bluebird Bio BLUE:US $ 15.3M 13.02M
Bristol Myers Squibb BMY:US $ 2451M 52M
Coherus Biosciences CHRS:US $ 16.7M 9.18M
Eli Lilly And LLY:US $ 1953.2M 74.6M
Gilead Sciences GILD:US $ 1390M 29M
GlaxoSmithKline GSK:LN 2519M 108M
Glaxosmithkline GSK:US $ 2519M 108M
Intercept Pharmaceuticals ICPT:US $ 0.62M 0.19M
Johnson & Johnson JNJ:US $ 7587M 551M
Merk MRK:US $ 2684M 771M
Moderna Inc MRNA:US 750M 557M
Neurocrine Biosciences NBIX:US $ 3.1M 0.2M
Novartis NOVN:VX SF 3754M 79M
Pfizer PFE:US $ 6992M 2820M
Ptc Therapeutics PTCT:US $ 7.36M 1.75M
Puma Biotechnology PBYI:US $ 11.97M 17.59M
Regeneron Pharmaceuticals REGN:US $ 693.7M 385.7M
Sarepta Therapeutics SRPT:US $ 19.52M 2.83M
Teva Pharmaceutical Industries TEVA:US $ 1987M 76M
United Therapeutics UTHR:US $ 37.2M 14.2M
Vertex Pharmaceuticals VRTX:US $ 227.97M 35.64M
YTE INCY:US $ 32.63M 8.81M